MSInsight
MSInsight develops MSIcare, an AI-driven software tool that detects microsatellite instability (MSI) from genomic data such as FASTQ and BAM files. The platform provides pan-cancer analysis for colorectal, endometrial, and gastric cancers to assist oncology professionals in predicting treatment responses. Its target market includes next-generation sequencing (NGS) laboratories, clinical practitioners, and the pharmaceutical industry.
Visit websiteParis, France
Healthtech
Oncology
Bioinformatics
Diagnostics
Artificial Intelligence
Funding summary
- Total raised
- €1.6M
- Funding rounds
- 1
Investors in MSInsight
Investors on record for MSInsight. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like MSInsight?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors